Cargando…
Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo
Epidemiologic studies implicate vitamin D status as a factor that influences growth of EGFR mutant lung cancers. However, laboratory based evidence of the biological effect of vitamin D in this disease is lacking. To fill this knowledge gap, we determined vitamin D receptor (VDR) expression in human...
Autores principales: | Verone-Boyle, Alissa R., Shoemaker, Suzanne, Attwood, Kristopher, Morrison, Carl D., Makowski, Andrew J., Battaglia, Sebastiano, Hershberger, Pamela A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808047/ https://www.ncbi.nlm.nih.gov/pubmed/26654942 |
Ejemplares similares
-
1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013) -
Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation
por: Mazahery, Hajar, et al.
Publicado: (2015) -
Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance
por: Shaurova, Tatiana, et al.
Publicado: (2020) -
25-Hydroxyvitamin D assay standardisation and vitamin D guidelines paralysis
por: Sempos, CT, et al.
Publicado: (2020) -
Gender, Obesity, Fat Distribution and 25-Hydroxyvitamin D
por: Guagnano, Maria Teresa, et al.
Publicado: (2023)